Esperion Therapeutics Inc. (0IIM)
Market Open
10 Jul, 15:30
LSE 
$
3. 19
+0
+0.1413%
$
- Market Cap
- P/E Ratio
- Div Yield
27,720 Volume
-1.97 Eps
$ 3.19
Previous Close Want to track 0IIM and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Esperion Therapeutics Inc. (0IIM) Statistics
Valuation metrics
Market Cap -
Enterprise value 1.05B
Trailing P/E (ttm) -131.4
Forward P/E -
PEG ratio -0.4
Price/Sales (ttm) 1.58
Price/Book (mrq) -2.6
Enterprise Value/Revenue 2.51
Enterprise Value/EBITDA 26.29
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 17.97K
Average volume (90 days) 43.58K
Price summary
52-Week low 1.1
52-Week high 4.17
Beta -
50-Day moving average 3.15
200-Day moving average 3.01
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate 3.16
Trailing annual dividend yield 0.9937%
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:10
Last split Date 17 May 2022
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -0.02%
Operating margin 0.18%
Operational effectiveness
Return on assets -0.02%
Return on equity 0.02%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 1.66
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -0.03
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 0.62
Total debt (mrq) -
Total Debt/Equity (mrq) -1.77
Current ratio (mrq) 1.53%
Book value per share (mrq) -1.23
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
